fbpx

Global DNA Vaccine Market Outlook to 2025 – The Market is Poised to Grow at Staggering Growth Rates – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global
DNA Vaccine Market Outlook 2025”
report has been added to ResearchAndMarkets.com’s
offering.

Several DNA vaccines are currently in clinical trials which are expected
to get approval soon. The industry has garnered the interest of
investors with funds pouring in from industry over and above development
funding provided by the government. The rise in R&D activities in the
industry is anticipated to propel the growth of the market.

Global DNA Vaccine Market Outlook 2025 provides an
in-depth analysis of the current scenario, the detailed market outlook
of the global DNA vaccine market overall as well as across various
geographies. Regional analysis is done across major markets in North
America, Europe, and the Asia Pacific.

The report provides comprehensive coverage on major industry drivers,
restraints, and their impact on market growth during the forecast
period. Furthermore, the study encompasses various market-specific
growth opportunities in global DNA vaccine market.

Major industry players operating in the global DNA vaccine market
include Novartis International, Merck & Co, GlaxoSmithKline, Sanofi
Pasteur, Pfizer, Astellas Pharma, Dendreon Corporation, among others.
These players are profiled herein based on attributes such as business
overview, product segments, and financial analysis. It also compiles the
performance comparison of the aforementioned companies and other leading
companies in the segment based on various parameters in the competitive
landscape section.

Geographical Coverage

  • North America
  • Europe
  • Asia Pacific

Key Vendors

  • Novartis International AG
  • Merck & Co. Inc.
  • GlaxoSmithKline PLC
  • Sanofi Pasteur S.A.
  • Pfizer Inc.
  • Astellas Pharma
  • Dendreon Corporation

Key Topics Covered

1. Executive Summary

2. Research Methodology

3. DNA Vaccines

3.1 Vaccines

3.2 Overview

3.2.1 History of DNA Vaccine

3.2.2 Components of Plasmid DNA Vaccine

3.3 DNA Vaccine Mechanism

3.4 DNA Vaccine Delivery Methods

4. Market Analysis

4.1 Market Sizing (Actual & Forecasted)

4.2 Market Share Analysis

4.2.1 Market Share by End-User

4.2.2 Market Share by Clinical Trials

4.2.3 Market Share by Region

5. Regional Analysis

5.1 North America

5.2 Europe

5.3 Asia Pacific

6. Market Dynamics

6.1 Industry Trends & Developments

6.1.1 DNA Vaccine Clinical Pipeline

6.1.2 Mergers & Acquisitions

6.1.3 Investments in the Industry

6.2 Growth Drivers

6.2.1 Higher Incidences of Infectious Diseases

6.2.2 Increasing Adoption in Animal Healthcare

6.2.3 Growing Demand for Novel Vaccines

6.2.4 Advantages over Conventional Vaccines

6.3 Challenges

6.3.1 Ambiguous Regulatory System

6.3.2 Less Market Penetration

6.3.3 Incompatibility with Other Vaccines

7. Competitive Landscape

8. Company Profiles

8.1 Novartis International AG

8.2 Merck & Co. Inc.

8.3 GlaxoSmithKline PLC

8.4 Sanofi Pasteur S.A.

8.5 Pfizer Inc.

For more information about this report visit https://www.researchandmarkets.com/r/svlybd

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Vaccines

leverton

Content is the most important part of having quality links to your website. With Area-Info.net, we provide a quality location to share your story and include links to your website to help you grow. If you would like to learn more, visit this page to see how you can use Area-Info.net to rank higher and quicker in search engines. Contact me directly at [email protected] with any questions, or to schedule speaking engagements.

You May Also Like